XML 18 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2018
Mar. 25, 2017
Operating activities:    
Net earnings $ 54,082,000 $ 29,527,000
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation of fixed assets 21,360,000 18,431,000
Amortization of intangibles and deferred costs 1,779,000 2,279,000
Share-based compensation 1,914,000 1,429,000
Deferred income taxes (15,360,000) (323,000)
Gain on redemption and sales of marketable securities (3,000)
Other (150,000) 498,000
Changes in assets and liabilities net of effects from purchase of companies    
Increase in accounts receivable (1,821,000) (7,940,000)
Increase in inventories (12,789,000) (10,866,000)
(Increase) decrease in prepaid expenses (2,560,000) 9,464,000
Decrease in accounts payable and accrued liabilities (4,555,000) (1,737,000)
Net cash provided by operating activities 41,897,000 40,762,000
Investing activities:    
Purchases of companies, net of cash acquired and debt assumed (31,111,000)
Purchases of property, plant and equipment (26,281,000) (32,983,000)
Purchases of marketable securities (47,172,000) (23,726,000)
Proceeds from redemption and sales of marketable securities 29,453,000 5,104,000
Proceeds from disposal of property and equipment 1,492,000 964,000
Other 86,000 (163,000)
Net cash used in investing activities (42,422,000) (81,915,000)
Financing activities:    
Payments to repurchase common stock (1,682,000)
Proceeds from issuance of stock 2,960,000 3,218,000
Payments on capitalized lease obligations (188,000) (182,000)
Payment of cash dividend (16,239,000) (15,133,000)
Net cash used in financing activities (13,467,000) (13,779,000)
Effect of exchange rate on cash and cash equivalents (1,765,000) 555,000
Net decrease in cash and cash equivalents (15,757,000) (54,377,000)
Cash and cash equivalents at beginning of period 90,962,000 140,652,000
Cash and cash equivalents at end of period $ 75,205,000 $ 86,275,000